Physician profile
John T Boyd
NPI 1730155946
$2,522.73
in general payments reported to CMS, 2019-2025
19 companies · $257 in 2025
The $257 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $407 · 2020: $362 · 2021: $400 · 2022: $539 · 2023: $258 · 2024: $301 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $950.02 | 2019-2025 | |
| Inari Medical, INC. | $309.02 | 2022 | |
| Abiomed | $241.52 | 2019-2020 | |
| Medtronic, INC. | $208.94 | 2021-2025 | Symplicity G3, Micra, Tyrx |
| Merck Sharp & Dohme LLC | $162.97 | 2021-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $141.05 | 2019-2021 | |
| Pfizer INC. | $127.62 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $74.38 | 2024-2025 | Eliquis, Camzyos |
| Amgen INC. | $55.95 | 2020-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $44.27 | 2020-2022 | |
| Abbott Laboratories | $37.49 | 2021-2023 | Cardiomems |
| W. L. Gore & Associates, INC. | $30.88 | 2024 | Gore Tag Conformable Thoracic Stent Graft |
| Sanofi-Aventis U.S. LLC | $29.70 | 2019 | |
| Silk Road Medical, INC. | $27.90 | 2022 | |
| Amarin Pharma, INC. | $19.03 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $18.52 | 2024 | Barostim Neo System |
| Regeneron Healthcare Solutions, INC. | $14.99 | 2019 | |
| Itamar Medical INC | $14.89 | 2023 | Watchpatone |
| Esperion Therapeutics, INC. | $13.59 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.